1 / 6

Enfiera 100mg injection - Rituximab | Apple Pharmaceuticals.

Enfiera 100mg administrating as two doses of 100mg IV infusion 2 weeks separated When glucocorticoids administered as methylprednisolone 100mg IV, Subsequent course based on clinical evaluation should administer every 24 weeks, but not early than every 16 weeks.

RobbieRoyce
Download Presentation

Enfiera 100mg injection - Rituximab | Apple Pharmaceuticals.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. APPLEPHARMACEUTICALS We will not dispense any prescription medication without a valid prescription from a licensed physician.

  2. RITUXIMAB Enfiera 100mg

  3. DESCRIPTION • PRESCRIBED FOR • Enfiera 100mg and hyaluronidase human injection are given alone or combination with another drugs to treat certain types of non-Hodgkin's lymphoma and chronic lymphocytic leukemia (cancer start in WBC). Enfiera 100mg injection is also used with methotrexate (Otrexup, Rasuvo, Xatmep, others) for the treatment rheumatoid arthritis symptoms in adults that have been already treated with a some type of regimen known as tumor necrosis factor (TNF) inhibitor. Enfiera is a anticancer medicine which prevents the growth and spread of cancer cells in the body. Enfiera also indicated for the treatment of Non- Hodgkins lymphoma or chronic lymphocytic and with combination with another anticancer drugs like methotrexate is used for rheumatoid arthritis symptoms in adult treatment.

  4. MECHANISM • DOSAGE • Enfiera 100mg is recommended to administer only through intravenous infusion not by IV push or bolus. • PREMEDICATE BEFORE EACH INFUSION First infusion: • initially rate of 50 mg/hr is given , in not showing infusion toxicity, rate raised upto 50 mg/hr increments at intervals of 30 min and max of 400 mg/hr. Successive infusion: 100 mg/hr initiated rate , in not showing infusion toxicity, rate raised upto 100 mg/hr increments at intervals of 30 min and max of 400 mg/hr. Premedication with corticosteroids must be considered, if Enfiera 100mg combination with CHOP chemotherapy is not given. Enfiera 100mg is a type of class called as monoclonal antibody and which is a new type of "targeted" cancer treatment and an integral part of the body's immune system. Naturally the body build antibodies in along with to an antigen which has entered the body and attach to the antigen for destruction by the immune system.

  5. PREGNANCY • Category C : animal studies reproduction shown an adverse effect on the fetus. The drug has no sufficient and well controlled studies in humans, using in pregnant women benefits by warrant use of the drug. • LACTATION • Enfiera 100mg excreted into human milk is unknown. Due to the drug belongs to large protein molecule, no information is available. Women should not breast feed during Enfiera 100mg treatment and 12 months following last dose. • STORAGE • Store at 2°C – 3°C Use the drug before expiry date Protected from direct sunlight Do not freeze or shake. Keep away from the children's Discard the unused drug by asking the advice from doctor or pharmacist.

  6. CALL CONTACT US • +91-9987711567 MAIL VISIT US • applepharmaceutical@gmail.com • http://anti-cancer-drugs.com/ ADDRESS Apartment No.304 A Wing, Shiva Shakthi chs ltd, JP Road, Near Apna Bazar,Andheri(West),Mumbai - 400058.

More Related